» Articles » PMID: 27583257

Factors Predicting Meniscal Allograft Transplantation Failure

Overview
Specialty Orthopedics
Date 2016 Sep 2
PMID 27583257
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Meniscal allograft transplantation (MAT) is performed to improve symptoms and function in patients with a meniscal-deficient compartment of the knee. Numerous studies have shown a consistent improvement in patient-reported outcomes, but high failure rates have been reported by some studies. The typical patients undergoing MAT often have multiple other pathologies that require treatment at the time of surgery. The factors that predict failure of a meniscal allograft within this complex patient group are not clearly defined.

Purpose: To determine predictors of MAT failure in a large series to refine the indications for surgery and better inform future patients.

Study Design: Cohort study; Level of evidence, 3.

Methods: All patients undergoing MAT at a single institution between May 2005 and May 2014 with a minimum of 1-year follow-up were prospectively evaluated and included in this study. Failure was defined as removal of the allograft, revision transplantation, or conversion to a joint replacement. Patients were grouped according to the articular cartilage status at the time of the index surgery: group 1, intact or partial-thickness chondral loss; group 2, full-thickness chondral loss 1 condyle; and group 3, full-thickness chondral loss both condyles. The Cox proportional hazards model was used to determine significant predictors of failure, independently of other factors. Kaplan-Meier survival curves were produced for overall survival and significant predictors of failure in the Cox proportional hazards model.

Results: There were 125 consecutive MATs performed, with 1 patient lost to follow-up. The median follow-up was 3 years (range, 1-10 years). The 5-year graft survival for the entire cohort was 82% (group 1, 97%; group 2, 82%; group 3, 62%). The probability of failure in group 1 was 85% lower (95% CI, 13%-97%) than in group 3 at any time. The probability of failure with lateral allografts was 76% lower (95% CI, 16%-89%) than medial allografts at any time.

Conclusion: This study showed that the presence of severe cartilage damage at the time of MAT and medial allografts were significantly predictive of failure. Surgeons and patients should use this information when considering the risks and benefits of surgery.

Citing Articles

Low Rates of 30-Day Postoperative Complications After Meniscal Allograft Transplantation: A Retrospective Study Using the National Surgical Quality Improvement Program Database.

Whitaker S, ONeill C, Satalich J, Protzuk O, Edge C, Hurley E Arthrosc Sports Med Rehabil. 2025; 7(1):101015.

PMID: 40041836 PMC: 11873519. DOI: 10.1016/j.asmr.2024.101015.


Outcome comparison of meniscal allograft transplantation (MAT) and meniscal scaffold implantation (MSI): a systematic review.

Dong J, Huang M, Lin J, Sun Y, Zhang X, Chen J Int J Surg. 2024; 110(8):5112-5123.

PMID: 38742839 PMC: 11325955. DOI: 10.1097/JS9.0000000000001587.


Risk Factors for Graft Failure After Meniscal Allograft Transplantation: A Systematic Review and Meta-analysis.

Kunze K, Davie R, Ramkumar P, Chahla J, Nwachukwu B, Williams 3rd R Orthop J Sports Med. 2023; 11(6):23259671231160296.

PMID: 37435586 PMC: 10331783. DOI: 10.1177/23259671231160296.


Guidelines on the Diagnosis and Treatment of Lateral Meniscal Lesions: A Consensus Statement by the Chinese Society of Sports Medicine.

Zhang S, Chen G, Li R, Yang C, Zheng J, Wang C Orthop J Sports Med. 2022; 10(12):23259671221138082.

PMID: 36532151 PMC: 9747892. DOI: 10.1177/23259671221138082.


Clinical significance and management of meniscal extrusion in different knee pathologies: a comprehensive review of the literature and treatment algorithm.

Makiev K, Vasios I, Georgoulas P, Tilkeridis K, Drosos G, Ververidis A Knee Surg Relat Res. 2022; 34(1):35.

PMID: 35851067 PMC: 9290229. DOI: 10.1186/s43019-022-00163-1.


References
1.
Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, Lindahl A . Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res. 2000; (374):212-34. DOI: 10.1097/00003086-200005000-00020. View

2.
Roos E, Lohmander L . The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003; 1:64. PMC: 280702. DOI: 10.1186/1477-7525-1-64. View

3.
Verdonk R, Volpi P, Verdonk P, VAN DER Bracht H, Van Laer M, Almqvist K . Indications and limits of meniscal allografts. Injury. 2013; 44 Suppl 1:S21-7. DOI: 10.1016/S0020-1383(13)70006-8. View

4.
McDermott I . What tissue bankers should know about the use of allograft meniscus in orthopaedics. Cell Tissue Bank. 2009; 11(1):75-85. DOI: 10.1007/s10561-009-9127-2. View

5.
Rath E, Richmond J, Yassir W, Albright J, Gundogan F . Meniscal allograft transplantation. Two- to eight-year results. Am J Sports Med. 2001; 29(4):410-4. DOI: 10.1177/03635465010290040401. View